EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX)

CUSIP: 269796108

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Shares outstanding
13,080,549
Total 13F shares
11,218,058
Share change
-54,972
Total reported value
$555,064,605
Price per share
$49.49
Number of holders
157
Value change
-$3,379,103
Number of buys
67
Number of sells
80

Quarterly Holders Quick Answers

What is CUSIP 269796108?
CUSIP 269796108 identifies EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q1 2022

As of 31 Mar 2022, EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) was held by 157 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,218,058 shares. The largest 10 holders included BlackRock Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, STATE STREET CORP, BRANDES INVESTMENT PARTNERS, LP, DIMENSIONAL FUND ADVISORS LP, AMERIPRISE FINANCIAL INC, Allspring Global Investments Holdings, LLC, JPMORGAN CHASE & CO, and Smith, Graham & Co., Investment Advisors, LP. This page lists 157 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.